Department of Clinical Chemistry and Hematology, Amphia Hospital, Breda, the Netherlands.
Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Int J Lab Hematol. 2018 Dec;40(6):726-733. doi: 10.1111/ijlh.12911. Epub 2018 Sep 2.
A flow cytometry score (FCS) based on four parameters has been proposed for analysis of myelodysplastic syndromes patients with <5% blasts. We evaluated whether bone marrow aspirate samples isolated from femoral heads could be used for verification of cutoff values of the individual parameters score (IPS), contributing to the FCS and compared the applicability of FCS parameters in two centers.
Bone marrow cells were obtained from femoral heads of patients who underwent hip replacement surgery. The score of the 4 individual parameters of the cell samples were obtained independently in two centers, using their own facilities and methods. Flow cytometry data files were subsequently exchanged and reanalyzed in the other center. The resulting four data sets were compared to assess reproducibility and outcomes in both centers.
Twenty-nine of 40 bone marrow samples contained sufficient cells for analysis. Proposed cutoff values for 3 of 4 individual parameters were appropriate. All 29 samples showed a positive individual parameters score (IPS:1) in 1 of the 4 obtained data sets. Most differences in IPS scores were a result of reanalyzing the data file in the other center, rather than data acquisition. FCS: ≥2 were observed in 11 samples.
Bone marrow samples from femoral heads are appropriate for verification of the proposed reference cutoff values of the individual parameters. Proposed reference cutoff values needed to be adjusted for reliable interpretation. Standardization of both data acquisition and data analysis is necessary for obtaining uniform results.
基于四个参数的流式细胞术评分(FCS)已被提出用于分析<5%blasts 的骨髓增生异常综合征患者。我们评估了从股骨头获得的骨髓抽吸样本是否可用于验证个体参数评分(IPS)的截止值,有助于 FCS,并比较了两个中心 FCS 参数的适用性。
从接受髋关节置换手术的患者的股骨头中获得骨髓细胞。在两个中心独立使用各自的设备和方法获得细胞样本的四个个体参数的评分。随后在另一个中心交换和重新分析流式细胞术数据文件。将四个数据集进行比较,以评估两个中心的可重复性和结果。
40 个骨髓样本中有 29 个含有足够的细胞进行分析。四个个体参数中的三个的建议截止值是合适的。在四个获得的数据集中的一个中,所有 29 个样本均显示出阳性的个体参数评分(IPS:1)。IPS 评分的大多数差异是由于在另一个中心重新分析数据文件,而不是数据采集。在 11 个样本中观察到 FCS:≥2。
股骨头的骨髓样本适合验证个体参数的建议参考截止值。需要调整建议的参考截止值以进行可靠的解释。为了获得一致的结果,需要对数据采集和数据分析进行标准化。